FR2626470B1 - Depresseur de l'inhibiteur de l'(alpha)2-plasmine - Google Patents
Depresseur de l'inhibiteur de l'(alpha)2-plasmineInfo
- Publication number
- FR2626470B1 FR2626470B1 FR8816071A FR8816071A FR2626470B1 FR 2626470 B1 FR2626470 B1 FR 2626470B1 FR 8816071 A FR8816071 A FR 8816071A FR 8816071 A FR8816071 A FR 8816071A FR 2626470 B1 FR2626470 B1 FR 2626470B1
- Authority
- FR
- France
- Prior art keywords
- acid addition
- physiologically acceptable
- acceptable acid
- addition salt
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 229940122791 Plasmin inhibitor Drugs 0.000 title 1
- 239000002806 plasmin inhibitor Substances 0.000 title 1
- 150000003839 salts Chemical class 0.000 abstract 8
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 abstract 6
- 239000002253 acid Substances 0.000 abstract 6
- 150000001875 compounds Chemical class 0.000 abstract 4
- JDVVGAQPNNXQDW-WCMLQCRESA-N Castanospermine Natural products O[C@H]1[C@@H](O)[C@H]2[C@@H](O)CCN2C[C@H]1O JDVVGAQPNNXQDW-WCMLQCRESA-N 0.000 abstract 2
- JDVVGAQPNNXQDW-TVNFTVLESA-N Castinospermine Chemical compound C1[C@H](O)[C@@H](O)[C@H](O)[C@H]2[C@@H](O)CCN21 JDVVGAQPNNXQDW-TVNFTVLESA-N 0.000 abstract 2
- BGMYHTUCJVZIRP-UHFFFAOYSA-N Nojirimycin Natural products OCC1NC(O)C(O)C(O)C1O BGMYHTUCJVZIRP-UHFFFAOYSA-N 0.000 abstract 2
- 125000003342 alkenyl group Chemical group 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000005018 aryl alkenyl group Chemical group 0.000 abstract 2
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 2
- 125000005160 aryl oxy alkyl group Chemical group 0.000 abstract 2
- 125000004181 carboxyalkyl group Chemical group 0.000 abstract 2
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 2
- 125000002768 hydroxyalkyl group Chemical group 0.000 abstract 2
- 239000002075 main ingredient Substances 0.000 abstract 2
- BGMYHTUCJVZIRP-GASJEMHNSA-N nojirimycin Chemical compound OC[C@H]1NC(O)[C@H](O)[C@@H](O)[C@@H]1O BGMYHTUCJVZIRP-GASJEMHNSA-N 0.000 abstract 2
- 102000003990 Urokinase-type plasminogen activator Human genes 0.000 abstract 1
- 108090000435 Urokinase-type plasminogen activator Proteins 0.000 abstract 1
- 102000003801 alpha-2-Antiplasmin Human genes 0.000 abstract 1
- 108090000183 alpha-2-Antiplasmin Proteins 0.000 abstract 1
- 239000003146 anticoagulant agent Substances 0.000 abstract 1
- 125000005020 hydroxyalkenyl group Chemical group 0.000 abstract 1
- 230000028327 secretion Effects 0.000 abstract 1
- 230000002537 thrombolytic effect Effects 0.000 abstract 1
- 229960005356 urokinase Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP31134887 | 1987-12-09 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2626470A1 FR2626470A1 (fr) | 1989-08-04 |
| FR2626470B1 true FR2626470B1 (fr) | 1994-12-09 |
Family
ID=18016066
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR8816071A Expired - Fee Related FR2626470B1 (fr) | 1987-12-09 | 1988-12-07 | Depresseur de l'inhibiteur de l'(alpha)2-plasmine |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0319986B1 (enExample) |
| KR (1) | KR960009417B1 (enExample) |
| AT (1) | ATE149836T1 (enExample) |
| BE (1) | BE1004874A4 (enExample) |
| CA (1) | CA1316831C (enExample) |
| CH (1) | CH677610A5 (enExample) |
| DE (1) | DE3855824T2 (enExample) |
| FR (1) | FR2626470B1 (enExample) |
| GB (2) | GB8827701D0 (enExample) |
| IL (1) | IL88573A (enExample) |
| SE (1) | SE502110C2 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0430983B1 (en) * | 1988-08-10 | 1994-04-20 | The Australian National University | Use of castanospermine as an anti-inflammatory and immunosuppressant agent |
| EP0966197A1 (en) * | 1996-08-14 | 1999-12-29 | Myung Hee Chun | Plasmin-depletion therapy |
| EP1903034A1 (en) * | 2006-09-19 | 2008-03-26 | Technische Universität Graz | Iminosugar glycoconjugates |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS54106477A (en) * | 1978-02-03 | 1979-08-21 | Nippon Shinyaku Co Ltd | Moranoline derivative |
| JPS5943946B2 (ja) * | 1978-04-28 | 1984-10-25 | 日本新薬株式会社 | Ｎ−アルケニルモラノリン誘導体 |
| GB2020278B (en) * | 1978-05-03 | 1983-02-23 | Nippon Shinyaku Co Ltd | Moranoline dervitives |
| JPS6026387B2 (ja) * | 1979-01-20 | 1985-06-24 | 日本新薬株式会社 | シンナミルモラノリン誘導体 |
| JPS5943949B2 (ja) * | 1978-09-29 | 1984-10-25 | 日本新薬株式会社 | モラノリンのｎ−置換誘導体 |
| JPS5943947B2 (ja) * | 1978-05-03 | 1984-10-25 | 日本新薬株式会社 | Ｎ−置換モラノリン誘導体 |
| DE2925943A1 (de) * | 1979-06-27 | 1981-01-29 | Bayer Ag | 1-alkadien-2,4-yl-2-hydroxymethyl3,4,5-trihydroxypiperidine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel |
| JPS56108767A (en) * | 1980-01-28 | 1981-08-28 | Nippon Shinyaku Co Ltd | Bismoranoline derivative |
| DE3007078A1 (de) * | 1980-02-26 | 1981-09-10 | Bayer Ag, 5090 Leverkusen | Neue derivate von 3,4,5-trihydroxypiperidin, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel sowie in der tierernaehrung |
| JPS60224675A (ja) * | 1984-04-24 | 1985-11-09 | Meiji Seika Kaisha Ltd | 新規１−デオキシノジリマイシン誘導体およびそれを含有する血中脂質低下剤 |
| CA1327970C (en) * | 1985-05-24 | 1994-03-22 | Paul S. Liu | Isolation of castanospermine and its use as an antidiabetic agent |
| WO1987003903A1 (en) * | 1985-12-23 | 1987-07-02 | Fred Hutchinson Cancer Research Center | Regulating retroviral replication, infection, and pathogenesis |
| ZA883925B (en) * | 1987-06-08 | 1989-02-22 | Merrell Dow Pharma | Inhibitors of glycoprotein processing having anti-retroviral activity |
-
1988
- 1988-11-28 GB GB888827701A patent/GB8827701D0/en active Pending
- 1988-11-30 GB GB8827927A patent/GB2213374B/en not_active Expired - Fee Related
- 1988-12-04 IL IL8857388A patent/IL88573A/xx not_active IP Right Cessation
- 1988-12-07 CH CH4527/88A patent/CH677610A5/fr not_active IP Right Cessation
- 1988-12-07 FR FR8816071A patent/FR2626470B1/fr not_active Expired - Fee Related
- 1988-12-08 SE SE8804436A patent/SE502110C2/sv not_active IP Right Cessation
- 1988-12-08 AT AT88120564T patent/ATE149836T1/de not_active IP Right Cessation
- 1988-12-08 DE DE3855824T patent/DE3855824T2/de not_active Expired - Fee Related
- 1988-12-08 EP EP88120564A patent/EP0319986B1/en not_active Expired - Lifetime
- 1988-12-08 BE BE8801375A patent/BE1004874A4/fr not_active IP Right Cessation
- 1988-12-09 CA CA000585530A patent/CA1316831C/en not_active Expired - Fee Related
- 1988-12-09 KR KR1019880016362A patent/KR960009417B1/ko not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA1316831C (en) | 1993-04-27 |
| GB8827701D0 (en) | 1988-12-29 |
| BE1004874A4 (fr) | 1993-02-16 |
| EP0319986A3 (en) | 1992-09-30 |
| SE502110C2 (sv) | 1995-08-21 |
| KR890009399A (ko) | 1989-08-01 |
| GB8827927D0 (en) | 1989-01-05 |
| ATE149836T1 (de) | 1997-03-15 |
| SE8804436L (sv) | 1989-06-10 |
| EP0319986B1 (en) | 1997-03-12 |
| KR960009417B1 (ko) | 1996-07-19 |
| GB2213374A (en) | 1989-08-16 |
| IL88573A (en) | 1994-05-30 |
| GB2213374B (en) | 1992-01-29 |
| CH677610A5 (enExample) | 1991-06-14 |
| SE8804436D0 (sv) | 1988-12-08 |
| FR2626470A1 (fr) | 1989-08-04 |
| DE3855824T2 (de) | 1997-10-16 |
| DE3855824D1 (de) | 1997-04-17 |
| EP0319986A2 (en) | 1989-06-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW288011B (enExample) | ||
| AU6690686A (en) | Piperdine derivative and pharmaceutical composition | |
| ATE36149T1 (de) | Antikonvulsive sulfamatderivate. | |
| PL344048A1 (en) | Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them | |
| DE69012840D1 (de) | Adenosin-Derivate, die eine Aktivität gegen Bluthochdruck haben. | |
| AU1433588A (en) | 1-phenyl-3-naphthalenyloxypropanamines | |
| ES8802421A1 (es) | Un procedimiento para la preparacion de un derivado de acido 5-imidazolcarboxilico | |
| ZA953981B (en) | New azolidinediones as antihyperglycemic agents | |
| CA2103590A1 (en) | Benzamide derivative | |
| DK0888337T3 (da) | Piperidon-tachykininantagonister | |
| EA200300044A1 (ru) | Новые замещенные фталиды, способ их получения и содержащие их фармацевтические композиции | |
| NO960441L (no) | Benzopyraner og farmasöytiske forbindelser inneholdende dem | |
| FR2626470B1 (fr) | Depresseur de l'inhibiteur de l'(alpha)2-plasmine | |
| EP0335979A4 (en) | Thienopyrimidine derivatives | |
| CA2014521A1 (en) | 2-Substituted N,N'-Ditrimethoxybenzoyl Piperazines, a Preparation Process of the Same and Therapeutic Compositions Containing Them | |
| CA2118425A1 (en) | Benzothiazolesulfonamide derivative, Method for Preparing the Same, and Use Thereof | |
| EP0123962A3 (en) | Novel benzimidazole derivative, process for the preparation thereof and pharmaceutical composition | |
| ATE50248T1 (de) | Ein imidazolidintrion-derivat oder ein seiner pharmazeutisch akzeptierbaren salze enthaltende pharmazeutische zusammenstellung. | |
| GR3007219T3 (enExample) | ||
| DE3674372D1 (de) | 1,2,3,4,4a,9b-hexahydro-4a-aminoalkyldibenzofurane, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. | |
| GB8801300D0 (en) | New compositions of matter | |
| EP0414903A4 (en) | New thioproline derivative | |
| EP0376162A3 (en) | Dental plaque inhibitor | |
| WO2001035938A3 (de) | Pharmakologisch aktive tetrahydrothiopyran-4-ol-derivate, verfahren zu ihrer herstellung und verwendung | |
| TNSN86099A1 (fr) | Nouveaux benzamides, leur procede de preparation et leur application dans le domaine therapeutique |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ST | Notification of lapse |